Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-006989
Filing Date
2023-03-08
Accepted
2023-03-08 16:20:39
Documents
2
Period of Report
2023-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167831042487970.html 4  
1 FORM 4 wf-form4_167831042487970.xml 4 3288
2 FOODY POA (INCLUDES SLK) ex24foody-copy.txt EX-24 3939
  Complete submission text file 0001628280-23-006989.txt   8718
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address
Foody Joanne M. (Reporting) CIK: 0001871467 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 23716373